181 related articles for article (PubMed ID: 33645441)
1. Investigation of
Camadan Y; Çiçek B; Adem Ş; Çalişir Ü; Akkemik E
J Biomol Struct Dyn; 2022 Sep; 40(15):6965-6973. PubMed ID: 33645441
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes.
Türkeş C; Demir Y; Beydemir Ş
J Biomol Struct Dyn; 2021 Mar; 39(5):1672-1680. PubMed ID: 32107977
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators.
Akocak S; Lolak N; Vullo D; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1305-1312. PubMed ID: 29072105
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
6.
Korkmaz IN; Güller P; Kalın R; Öztekin A; Özdemir H
Curr Comput Aided Drug Des; 2022; 18(5):381-392. PubMed ID: 35984020
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
8. The effects of some bromophenols on human carbonic anhydrase isoenzymes.
Taslimi P; Gülçin İ; Öztaşkın N; Çetinkaya Y; Göksu S; Alwasel SH; Supuran CT
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):603-7. PubMed ID: 26133541
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI.
Sentürk M; Ekinci D; Göksu S; Supuran CT
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):365-9. PubMed ID: 21699374
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
Sarikaya B; Ceruso M; Carta F; Supuran CT
Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and carbonic anhydrase isoenzymes inhibitory effects of brominated diphenylmethanone and its derivatives.
Çetinkaya Y; Göçer H; Gülçin I; Menzek A
Arch Pharm (Weinheim); 2014 May; 347(5):354-9. PubMed ID: 24599599
[TBL] [Abstract][Full Text] [Related]
12. The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII).
Scozzafava A; Kalın P; Supuran CT; Gülçin İ; Alwasel SH
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):941-6. PubMed ID: 25586344
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
14. Novel 1,3,5-Triazinyl Aminobenzenesulfonamides Incorporating Aminoalcohol, Aminochalcone and Aminostilbene Structural Motifs as Potent Anti-VRE Agents, and Carbonic Anhydrases I, II, VII, IX, and XII Inhibitors.
Havránková E; Garaj V; Mascaretti Š; Angeli A; Soldánová Z; Kemka M; Motyčka J; Brázdová M; Csöllei J; Jampílek J; Supuran CT
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008657
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the effects of some pesticides on carbonic anhydrase isoenzymes.
Baltacı A; Cıkrıkcı K; Gençer N
J Mol Recognit; 2023 Sep; 36(9):e3048. PubMed ID: 37551992
[TBL] [Abstract][Full Text] [Related]
16. The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.
Taslimi P; Gulcin I; Ozgeris B; Goksu S; Tumer F; Alwasel SH; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(1):152-7. PubMed ID: 25697270
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and docking studies of benzenesulfonamide derivatives containing 1,2,3-triazole as potential ınhibitor of carbonic anhydrase I-II enzymes.
Güngör SA; Köse M; Tümer M; Türkeş C; Beydemir Ş
J Biomol Struct Dyn; 2023 Dec; 41(20):10919-10929. PubMed ID: 36576122
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease.
Koçyiğit ÜM; Gezegen H; Taslimi P
Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000202. PubMed ID: 32815568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
